North America
Ambrx Begins Phase I Trial of ARX517 in PSMA-Expressing Tumors
The Phase I dose escalation and dose expansion study is enrolling up to 76 patients with PSMA-expressing solid tumors.
SpringWorks, MSK Collaborate to Study MEK Inhibitor in Certain Solid TumorsÂ
The partners will explore the activity of mirdametinib with fulvestrant in breast cancer patients with MAPK alterations and as a single agent in other MAPK-altered solid tumors.
UPMC, Avalon GloboCare Ink Partnership to Advance CAR T-Cell Treatments
Researchers at the university will use Avalon's FLASH-CAR technology to speed up the development of treatments and improve their efficacy against cancer cells.
InterVenn Biosciences Closes $201M Series C Round
The company said it planned to use the funds for the development of a liquid biopsy assay for predicting patient response to immune checkpoint inhibitors.
In Brief This Week: Day One, Sophia Genetics, Genetron Health, Global Cancer Technology
News items for the week of July 26, 2021.
Jul 30, 2021
Jul 28, 2021
Strata Oncology Raises $90M in Series C Financing
Jul 28, 2021
Jul 27, 2021
Artios Pharma Raises $153M in Series C Funding
Jul 22, 2021